Salarius Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Browse to the end of the page for potential risks for Salarius Pharmaceuticals Inc based on sector, geography and marketcap. If you are employed by Salarius Pharmaceuticals Inc and you would like to use your Sustainability aseessment, please contact us. The Disclosure score includes 17 UN SDGs including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Peace, Justice & Strong Institutions'.
Salarius Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 5.3, social score of 4.8 and governance score of 5.3.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 886 | Veracyte Inc | 5.4 | High |
| 886 | Xlife Sciences AG | 5.4 | High |
| 912 | Salarius Pharmaceuticals Inc | 5.3 | High |
| 912 | Acer Therapeutics Inc | 5.3 | High |
| 912 | Alembic Pharmaceuticals Ltd | 5.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Salarius Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Salarius Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Salarius Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Salarius Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Salarius Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Salarius Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Salarius Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. The company is headquartered in Houston, Texas.